Exposure to Endocrine Disruptors (Di(2-Ethylhexyl)phthalate (DEHP) and Bisphenol A (BPA)) in Women from Different Residing Areas in Italy: Data from the LIFE PERSUADED Project.

bisphenol A di-(2-ethylhexyl) phthalate endocrine-disrupting chemicals geographical area human biomonitoring women exposure

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
16 Dec 2022
Historique:
received: 21 10 2022
revised: 30 11 2022
accepted: 10 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Phthalates and bisphenol A (BPA) are plasticizers used in many industrial products that can act as endocrine disruptors and lead to metabolic diseases. During the LIFE PERSUADED project, we measured the urinary concentrations of BPA and Di(2-ethylhexyl)phthalate (DEHP) metabolites in 900 Italian women representative of the Italian female adult population (living in the north, centre, and south of Italy in both rural and urban areas). The whole cohort was exposed to DEHP and BPA with measurable levels above limit of detection in more than 99% and 95% of the samples, respectively. The exposure patterns differed for the two chemicals in the three macro-areas with the highest urinary levels for DEHP in south compared to central and northern Italy and for BPA in northern compared to central and southern Italy. BPA levels were higher in women living in urban areas, whereas no difference between areas was observed for DEHP. The estimated daily intake of BPA was 0.11 μg/kg per day, about 36-fold below the current temporary tolerable daily intake of 4 μg/kg per day established by the EFSA in 2015. The analysis of cumulative exposure showed a positive correlation between DEHP and BPA. Further, the reduction of exposure to DEHP and BPA, through specific legislative measures, is necessary to limit the harmfulness of these substances.

Identifiants

pubmed: 36555656
pii: ijms232416012
doi: 10.3390/ijms232416012
pmc: PMC9783390
pii:
doi:

Substances chimiques

Diethylhexyl Phthalate C42K0PH13C
bisphenol A MLT3645I99
Endocrine Disruptors 0
Phthalic Acids 0
Benzhydryl Compounds 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Commission
ID : LIFE13 ENV/IT/000482

Références

Annu Rev Public Health. 2010;31:179-94
pubmed: 20070188
Mol Nutr Food Res. 2007 Jul;51(7):899-911
pubmed: 17604388
Int J Mol Sci. 2021 Apr 22;22(9):
pubmed: 33922211
Environ Health. 2015 Jun 20;14:54
pubmed: 26092037
Obes Rev. 2021 Nov;22(11):e13332
pubmed: 34409721
Environ Health Perspect. 2015 Mar;123(3):255-63
pubmed: 25493439
Int J Environ Res Public Health. 2017 Nov 25;14(12):
pubmed: 29186834
Environ Int. 2014 Dec;73:323-33
pubmed: 25216151
Environ Health Perspect. 2005 Nov;113(11):1530-5
pubmed: 16263507
Int J Environ Res Public Health. 2021 Apr 26;18(9):
pubmed: 33925988
EFSA J. 2019 Dec 11;17(12):e05838
pubmed: 32626195
Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Environ Res. 2019 Aug;175:297-307
pubmed: 31146101
Environ Health Perspect. 2010 Nov;118(11):1603-8
pubmed: 20797929
Environ Res. 2020 Jun;185:109428
pubmed: 32251910
Int J Androl. 2008 Apr;31(2):131-8
pubmed: 18070048
Arch Toxicol. 2004 Mar;78(3):123-30
pubmed: 14576974
J Anthropol Sci. 2014;92:201-31
pubmed: 24607994
Front Public Health. 2020 Sep 24;8:553850
pubmed: 33072697
Environ Res. 2022 Jul;210:112933
pubmed: 35182598
Toxicol Sci. 2004 Mar;78(1):50-9
pubmed: 14691209
Rev Endocr Metab Disord. 2020 Mar;21(1):127-147
pubmed: 31792807
J Med Toxicol. 2006 Sep;2(3):126-35
pubmed: 18077888
Int J Hyg Environ Health. 2013 Nov;216(6):772-83
pubmed: 23528233
Int J Hyg Environ Health. 2003 Mar;206(2):77-83
pubmed: 12708228
Food Chem Toxicol. 2021 Aug;154:112325
pubmed: 34097988
Ecotoxicol Environ Saf. 2021 Sep 15;221:112453
pubmed: 34186418
Am J Physiol Endocrinol Metab. 2011 Sep;301(3):E527-38
pubmed: 21673306
Int J Environ Res Public Health. 2021 Nov 12;18(22):
pubmed: 34831602
Sci Total Environ. 2021 Jun 25;775:145755
pubmed: 34132197
Metabolites. 2022 Feb 10;12(2):
pubmed: 35208241
Int J Hyg Environ Health. 2015 Jan;218(1):47-57
pubmed: 25159680
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2011 May;28(5):676-85
pubmed: 21400322
Nat Rev Endocrinol. 2017 Aug;13(8):445-457
pubmed: 28524171
Environ Sci Pollut Res Int. 2018 Sep;25(25):25618-25625
pubmed: 29974441
J Hazard Mater. 2022 Mar 5;425:127911
pubmed: 34910997
J Clin Endocrinol Metab. 2019 May 1;104(5):1491-1499
pubmed: 30462244
Arch Environ Contam Toxicol. 2017 Oct;73(3):410-420
pubmed: 28770280
PLoS One. 2018 Nov 27;13(11):e0208081
pubmed: 30481198

Auteurs

Fabrizia Carli (F)

Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

Sabrina Tait (S)

Centre for Gender-Specific Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.

Luca Busani (L)

Centre for Gender-Specific Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.

Demetrio Ciociaro (D)

Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

Veronica Della Latta (V)

Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

Anna Paola Pala (AP)

Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

Annalisa Deodati (A)

Dipartimento Pediatrico, Universitario Ospedaliero "Bambino Gesù" Children's Hospital, 00165 Rome, Italy.
Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.

Andrea Raffaelli (A)

Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

Filippo Pratesi (F)

Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

Raffaele Conte (R)

Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

Francesca Maranghi (F)

Centre for Gender-Specific Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.

Roberta Tassinari (R)

Centre for Gender-Specific Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.

Enrica Fabbrizi (E)

Unità Operativa Dipartimentale di Pediatria, Asur Marche Area Vasta 3, Ospedale di Civitanova Marche, 62012 (MC), Italy.

Giacomo Toffol (G)

Associazione Culturale Pediatri, 09070 Narbolia, Italy.

Stefano Cianfarani (S)

Dipartimento Pediatrico, Universitario Ospedaliero "Bambino Gesù" Children's Hospital, 00165 Rome, Italy.
Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Department of Women's and Children's Health, Karolinska Institute and University Hospital, 171 77 Stockholm, Sweden.

Cinzia La Rocca (C)

Centre for Gender-Specific Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.

Amalia Gastaldelli (A)

Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH